Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic methylprednisolone versus dexamethasone for Meniere's disease and tinnitus
IRCT2015102912691N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylprednisolone and dexamethasone in Meniere Disease and tinnitus (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Effectiveness in endolymphatic hydrops cure and Effectiveness in tinnitus improvement. Started Jan 2016; status: completed.
02
Drugs
methylprednisolonedexamethasone
03
Conditions
Meniere Diseasetinnitus
Beyond the preview
Go deeper on IRCT2015102912691N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015102912691N3.